The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, ...

OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a ...

Nicole Kleinstreuer, who is leading an NIH effort to reduce the use of animals in research, began thinking about the issue as a toxicologist at the EPA ...

Flexible cystoscopy is the most common office-based procedure performed by urologists to diagnose and treat lower urinary tract conditions.

The FDA has granted Fast Track designation to SAR446268 for the treatment of non-congenital myotonic dystrophy type 1.

In late September, the U.S. Food & Drug Administration (“FDA”) issued three draft guidances related to cell and gene therapy (“CGT”) products: (1) Innovative Designs for C ...

The entire rationale behind this multi-pronged screening was the discovery of checkpoints or regulators that are critically involved in inducing suppression in NK cells under these diverse negative ...

Dr. Kates’ experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the ...

Chandler H. Park, MD, a medical oncologist at Norton Cancer Institute and advisory dean/professor at University of Louisville in Kentucky, discusses the Category 1 treatment options for metastatic ...